First results of Russian COVID vaccine trial to include data from 5,000-10,000

Interim results from Russia’s late-stage human trial of a COVID-19 vaccine could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.

The trial of the Sputnik V vaccine, involving 40,000 volunteers, has been under way in Moscow since the beginning of September. Interim results are expected to be published in November.

https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-dat/first-results-of-russian-covid-vaccine-trial-to-include-data-from-5000-10000-people-developers-idUSKBN27422I